A Day Up For Kezar Life Sciences, Inc.
Tue, Nov 16, 2021 at 05:30 PM
Kezar Life Sciences, Inc. (KZR:NASDAQ) shot up at $11.59, a gain of 37.8%. On Mon, Nov 15, 2021, KZR:NASDAQ hit a New 2-Week Intraday High of $8.89. The stock appeared on our News Catalysts scanner on Tue, Nov 16, 2021 at 02:24 PM in the 'MISCELLANEOUS' category. From Mon, Nov 01, 2021, the stock recorded 60.00% Up Days and 45.45% Green Days
The share price of the company has been moving sideways in recent weeks.
About Kezar Life Sciences, Inc. (KZR:NASDAQ)
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer.
Top 10 Gainers:
- BOQI International Medical Inc. (BIMI:NASDAQ), 54.97%
- ReTo Eco-Solutions, Inc. (RETO:NASDAQ), 48.37%
- PROG (PROG:NASDAQ), 39.48%
- Kezar Life Sciences, Inc. (KZR:NASDAQ), 37.81%
- IONQ (IONQ:NYSE), 33.1%
- PLBY (PLBY:NASDAQ), 31.58%
- Trio-Tech International (TRT:NYSEMKT), 30.31%
- IONM (IONM:NASDAQ), 25.77%
- Tricida, Inc. (TCDA:NASDAQ), 25.51%
- Second Sight Medical Products, Inc. (EYES:NASDAQ), 25.37%